​***If you do not receive your event confirmation within 1 business day of RSVPing (above), check your email spam folder. The automated Luma email includes the Zoom info and cal invite.***

​Comm Convo pricing:

• ​Complimentary for T2B Pro and Student community members (log into your T2B account and access your promo code here)

• ​$40 for Basic members (access to live event only, not the recording)

​If you're not part of Ticket to Biotech, confirm you're eligible, and join before registering for this event:

​Request to join T2B

​COMM CONVO: WHY ONLY SOME PLATFORMS ARE TRUSTED WHEN EVERYONE HAS ONE

​The most trusted voice on any given biopharma issue is increasingly someone who does not report to communications. The 2026 Edelman Trust Barometer shows medical scientists and experts at 68% trust in the U.S., down 7 points from last year, while healthcare CEOs land at 27% and journalists sit barely above them at 28%. For senior communicators, this creates a genuinely complicated operating reality: we are building narratives and managing reputations in a landscape where a researcher's independent Substack can carry more weight than a corporate press release, and where the most credible voice on a given issue may not sit in our department or report to anyone in our chain of command. This session brings together communications leaders to examine what the credibility shift means for how we identify, activate, and work alongside the voices our organizations need.

​WHY ATTEND

• ​Reframe your spokesperson strategy around the scientific, clinical, and community voices your audiences already trust.

• ​Navigate the balance of developing employees and experts as credible communicators without creating brand, legal, or compliance risk.

• ​Rethink your channel architecture on where your messages earn trust, where they lose it, and why platform choice now carries as much weight for credibility as it does for reach.

• ​Pressure-test your assumptions about who speaks for your organization and when, as the gap between institutional authority and actual audience trust continues to grow.

​FEATURED SPEAKERS

• ​Chloe Kirk, PhD, Science Correspondent, BiotechTV

• ​Benjamin McLeod, Founder, Convey Bio

​PANEL MODERATOR

• ​Gwendolyn Wu, Senior Reporter, BioPharma Dive

​MEET OUR SPEAKERS

​Chloe Kirk, PhD, Science Correspondent, BiotechTV

​Chloe Kirk, PhD, is a biochemist and science communicator reaching 120K+ through social-first biomedical storytelling. She's a Science Correspondent for BiotechTV, and, beyond the science, loves to bake, read, and hang out with her two cats.

​Benjamin McLeod, Founder, Convey Bio

​Ben is a scientist-turned-entrepreneur. He runs an agency that focuses on social media content strategy for biotech companies, while also being the co-host of the Biotech Voyager. He is married with two children and one more on the way.

​Gwendolyn Wu, Senior Reporter, Biopharma Dive (Moderator)

​Gwendolyn Wu is a senior reporter at BioPharma Dive covering biotech startups, venture capital and the ecosystem that supports them. Previously, she authored Bay Briefing, the San Francisco Chronicle’s flagship weekday newsletter, and covered COVID-19 and the business of healthcare for the Houston Chronicle. Outside of the newsroom, Gwendolyn co-directs the AAJA Young Professionals Network, and teaches at the California Scholastic Press Association summer workshop. She has degrees in history and sociology from the University of California at Santa Barbara.